ロード中...
HER2 and breast cancer stem cells: More than meets the eye
The development of HER2-targeting agents has dramatically altered the natural history of HER2-positive breast cancer and is often cited as a prime example of the effectiveness of molecularly targeted therapy. Emerging data suggests that the remarkable clinical efficacy of these agents may be related...
保存先:
| 出版年: | Cancer Res |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4389902/ https://ncbi.nlm.nih.gov/pubmed/23740771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0260 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|